920.2500 6.90 (0.76%)
NSE May 06, 2025 15:31 PM
Volume: 148.1K
 

920.25
0.76%
ICICI Securities Limited
Thyrocare Technologies(Thyrocare) Q2FY23 performance was below our estimates on all fronts. Non-covid pathology revenue grew by 4.6% QoQ, but volumes were flat sequentially.
Thyrocare Technologies Ltd. has gained 45.83% in the last 1 Year
More from Thyrocare Technologies Ltd.
Recommended